Public Policy Resources

Breast cancer is the most common cancer diagnosed in women in the U.S. Although there has been substantial progress in reducing breast cancer mortality in the US over the past several decades, there are persistent disparities, especially among Black women. Additionally, breast cancer incidence is increasing, with the steepest trends among young women under 50. In 2025, an estimated 316,950 women in the U.S. will be diagnosed with invasive breast cancer with an additional 59,080 cases of ductal carcinoma in situ (DCIS) in women, and 42,680 will die from the disease. 

The Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program (CRCCP) provides grant funding to 20 state health departments, eight universities, two tribal organizations, and five other organizations to help prevent colorectal cancer, the third most common cancer in men and women and the second leading cause of cancer death in the U.S. for men and women combined.

Sustained, dedicated federal investment in tobacco control through the Centers for Disease Control and Prevention’s Office of Smoking and Health (OSH) is necessary to prevent initiation of tobacco products, monitor tobacco product use, identify tobacco related disparities, and promote effective strategies to help individuals who use tobacco products to successfully quit.

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2025 to accelerate progress in reducing mortality from lung cancer. 

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) appreciate the opportunity to comment on the scientific report of the 2025 Dietary Guidelines Advisory Committee. Overall, we strongly support the conclusions and recommendations in the DGAC Report. The following comments provide additional information on the role of diet in cancer and specific recommendations for those tasked with finalizing the 2025-2030 Dietary Guidelines for Americans (DGA).

Comprehensive tobacco retailer licensing laws can reduce the harmful impact of the tobacco retail environment by regulating where and how tobacco retailers can operate and sell tobacco products as well as providing the licensing entity the authority to ensure tobacco retailers are complying with all applicable tobacco control laws.

In 1999, the U.S. Department of Justice (DOJ) filed a lawsuit against major tobacco manufacturers Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria to hold the industry accountable for more than 50 years of conspiring to defraud the public in violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. Big Tobacco, an industry which has for decades knowingly addicted and endangered the lives of millions of Americans for their own profit, must now post the truth about their deadly products, including at the point-of-sale (POS) for approximately 220,000 tobacco retailers.

The tobacco industry has a history of using litigation to avoid and delay laws and regulations enacted to safeguard the public. ACS CAN, with our tobacco control partners, has also relied on the courts to hold Big Tobacco accountable and to ensure the federal government is effectively implementing the Tobacco Control Act.

Implementation of graphic warnings in the U.S. has been thwarted by tobacco industry legal challenges. The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), along with our partners, have fought back in the judicial system, using litigation to both compel the U.S. Food and Drug Administration (FDA) to issue graphic warning regulations and help the U.S. Department of Justice (DOJ) defend the regulations finalized by FDA.